[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
| 1997 | 0 | 0.24 | 0 | 0 | 10 | 10 | 17 | 1 | 0 | 0 | 0 | 0 | 0.11 | |||||
| 1998 | 0 | 0.28 | 0 | 0 | 12 | 22 | 8 | 1 | 10 | 10 | 0 | 0 | 0.13 | |||||
| 2000 | 0 | 0.34 | 0.03 | 0.05 | 9 | 31 | 15 | 1 | 7 | 12 | 22 | 1 | 0 | 0 | 0.16 | |||
| 2001 | 0 | 0.38 | 0.09 | 0.1 | 3 | 34 | 4 | 3 | 10 | 9 | 31 | 3 | 2 | 66.7 | 0 | 0.17 | ||
| 2002 | 0.08 | 0.39 | 0.08 | 0.09 | 3 | 37 | 0 | 3 | 13 | 12 | 1 | 34 | 3 | 0 | 0 | 0.21 | ||
| 2003 | 0 | 0.43 | 0.12 | 0.11 | 5 | 42 | 13 | 5 | 18 | 6 | 27 | 3 | 1 | 20 | 0 | 0.21 | ||
| 2004 | 0.13 | 0.47 | 0.07 | 0.1 | 1 | 43 | 3 | 3 | 21 | 8 | 1 | 20 | 2 | 0 | 0 | 0.21 | ||
| 2005 | 0.17 | 0.51 | 0.04 | 0.05 | 7 | 50 | 14 | 2 | 23 | 6 | 1 | 21 | 1 | 0 | 0 | 0.23 | ||
| 2006 | 0 | 0.5 | 0.16 | 0.11 | 62 | 112 | 132 | 18 | 41 | 8 | 19 | 2 | 15 | 83.3 | 13 | 0.21 | 0.22 | |
| 2007 | 0.09 | 0.44 | 0.08 | 0.09 | 38 | 150 | 101 | 12 | 53 | 69 | 6 | 78 | 7 | 5 | 41.7 | 2 | 0.05 | 0.2 |
| 2008 | 0.07 | 0.47 | 0.06 | 0.08 | 22 | 172 | 315 | 11 | 64 | 100 | 7 | 113 | 9 | 4 | 36.4 | 0 | 0.22 | |
| 2009 | 0.18 | 0.46 | 0.11 | 0.13 | 28 | 200 | 85 | 22 | 86 | 60 | 11 | 130 | 17 | 8 | 36.4 | 1 | 0.04 | 0.23 |
| 2010 | 0.44 | 0.46 | 0.22 | 0.27 | 33 | 233 | 81 | 51 | 137 | 50 | 22 | 157 | 42 | 11 | 21.6 | 0 | 0.2 | |
| 2011 | 0.13 | 0.5 | 0.17 | 0.16 | 32 | 265 | 128 | 46 | 183 | 61 | 8 | 183 | 30 | 16 | 34.8 | 5 | 0.16 | 0.23 |
| 2012 | 0.42 | 0.5 | 0.35 | 0.39 | 94 | 359 | 199 | 127 | 310 | 65 | 27 | 153 | 59 | 64 | 50.4 | 26 | 0.28 | 0.21 |
| 2013 | 0.31 | 0.53 | 0.28 | 0.32 | 97 | 456 | 480 | 126 | 436 | 126 | 39 | 209 | 66 | 38 | 30.2 | 27 | 0.28 | 0.23 |
| 2014 | 0.2 | 0.52 | 0.21 | 0.2 | 111 | 567 | 420 | 118 | 554 | 191 | 39 | 284 | 56 | 29 | 24.6 | 18 | 0.16 | 0.22 |
| 2015 | 0.31 | 0.52 | 0.28 | 0.28 | 106 | 673 | 406 | 189 | 743 | 208 | 64 | 367 | 103 | 31 | 16.4 | 16 | 0.15 | 0.22 |
| 2016 | 0.27 | 0.49 | 0.25 | 0.27 | 133 | 806 | 323 | 205 | 948 | 217 | 59 | 440 | 120 | 36 | 17.6 | 12 | 0.09 | 0.2 |
| 2017 | 0.28 | 0.51 | 0.28 | 0.26 | 116 | 922 | 338 | 254 | 1203 | 239 | 67 | 541 | 140 | 60 | 23.6 | 28 | 0.24 | 0.2 |
| 2018 | 0.27 | 0.52 | 0.29 | 0.31 | 128 | 1050 | 218 | 308 | 1511 | 249 | 68 | 563 | 177 | 40 | 13 | 12 | 0.09 | 0.22 |
| 2019 | 0.29 | 0.53 | 0.32 | 0.27 | 132 | 1182 | 279 | 377 | 1888 | 244 | 71 | 594 | 162 | 60 | 15.9 | 34 | 0.26 | 0.21 |
| 2020 | 0.24 | 0.63 | 0.33 | 0.3 | 118 | 1300 | 147 | 430 | 2318 | 260 | 62 | 615 | 182 | 34 | 7.9 | 15 | 0.13 | 0.3 |
| 2021 | 0.23 | 0.72 | 0.31 | 0.24 | 114 | 1414 | 121 | 445 | 2763 | 250 | 58 | 627 | 150 | 38 | 8.5 | 18 | 0.16 | 0.26 |
| 2022 | 0.23 | 0.71 | 0.3 | 0.28 | 120 | 1534 | 91 | 466 | 3229 | 232 | 53 | 608 | 169 | 28 | 6 | 25 | 0.21 | 0.21 |
| 2023 | 0.11 | 0.66 | 0.21 | 0.17 | 105 | 1639 | 76 | 351 | 3580 | 234 | 25 | 612 | 104 | 24 | 6.8 | 16 | 0.15 | 0.19 |
| 2024 | 0.16 | 0.71 | 0.21 | 0.17 | 113 | 1752 | 48 | 361 | 3941 | 225 | 35 | 589 | 100 | 18 | 5 | 11 | 0.1 | 0.21 |
| 2025 | 0.22 | 0.94 | 0.21 | 0.16 | 107 | 1859 | 27 | 387 | 4328 | 218 | 47 | 570 | 94 | 74 | 19.1 | 13 | 0.12 | 0.27 |
| 2026 | 0.15 | 0.13 | 0.1 | 40 | 1899 | 0 | 244 | 4572 | 220 | 33 | 559 | 54 | 90 | 36.9 | 0 |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2013 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Moher, David ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers || Download paper | 261 |
| 2 | 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 244 |
| 3 | 2014 | Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers || Download paper | 111 |
| 4 | 2019 | Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Soekhai, Vikas ; Bekker-Grob, Esther W ; Ellis, Alan R. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers || Download paper | 97 |
| 5 | 2017 | Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers || Download paper | 84 |
| 6 | 2016 | Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers || Download paper | 63 |
| 7 | 2015 | The Epidemiology of Obesity: A Big Picture. (2015). Hu, Frank ; Hruby, Adela . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689. Full description at Econpapers || Download paper | 52 |
| 8 | 2013 | How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers || Download paper | 41 |
| 9 | 2016 | EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Oppe, Mark ; Rand-Hendriksen, Kim ; Ramosgoi, Juan M. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers || Download paper | 40 |
| 10 | 2014 | A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers || Download paper | 39 |
| 11 | 2015 | The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Suhrcke, Marc ; Seuring, Till ; Archangelidi, Olga. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. Full description at Econpapers || Download paper | 37 |
| 12 | Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 34 | |
| 13 | 2014 | Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers || Download paper | 33 |
| 14 | 2015 | Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Meyerhoefer, Chad ; Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722. Full description at Econpapers || Download paper | 30 |
| 15 | 2019 | Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Le, Phuc ; Mullen, Patricia Dolan ; Zhang, LU ; Chiyaka, Edward T ; Deshpande, Abhishek ; Nghiem, Van T. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. Full description at Econpapers || Download paper | 29 |
| 16 | 2017 | The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Trapero-Bertran, Marta ; Pea-Longobardo, Luz Maria ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers || Download paper | 28 |
| 17 | 2012 | Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Light, Kate ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn ; Woolacott, Nerys ; Bojke, Laura. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270. Full description at Econpapers || Download paper | 27 |
| 18 | 2014 | How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers || Download paper | 27 |
| 19 | 2017 | International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Zouraq, Ismail Azzabi ; Chevrou-Severac, Helene ; Rowen, Donna ; Hout, Ben. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. Full description at Econpapers || Download paper | 25 |
| 20 | 2009 | Cost Effectiveness in Low- and Middle-Income Countries. (2009). Shillcutt, Samuel ; Walker, Damian ; Goodman, Catherine ; Mills, Anne. In: PharmacoEconomics. RePEc:spr:pharme:v:27:y:2009:i:11:p:903-917. Full description at Econpapers || Download paper | 25 |
| 21 | 2018 | German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. Full description at Econpapers || Download paper | 24 |
| 22 | 2015 | The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration. (2015). Gray, Alastair ; Froud, Robert ; Rivero-Arias, Oliver ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:993-1011. Full description at Econpapers || Download paper | 24 |
| 23 | 2018 | Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. Full description at Econpapers || Download paper | 23 |
| 24 | 2015 | Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135. Full description at Econpapers || Download paper | 22 |
| 25 | 2015 | A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. Full description at Econpapers || Download paper | 22 |
| 26 | 2014 | Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime ; Neasham, David . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365. Full description at Econpapers || Download paper | 21 |
| 27 | 2018 | A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5. Full description at Econpapers || Download paper | 21 |
| 28 | 2014 | The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86. Full description at Econpapers || Download paper | 21 |
| 29 | 2020 | Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?. (2020). Devlin, Nancy ; Rivero-Arias, Oliver ; Ratcliffe, Julie ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00873-7. Full description at Econpapers || Download paper | 20 |
| 30 | 2021 | The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). (2021). Kessler, Ronald C ; Berman, Richard ; Greenberg, Paul E ; Simes, Mark ; Fournier, Andree-Anne ; Sisitsky, Tammy ; Koenigsberg, Sarah H. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01019-4. Full description at Econpapers || Download paper | 20 |
| 31 | 2014 | Preferences for Oral Anticoagulants in Atrial Fibrillation: a BestâBest Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127. Full description at Econpapers || Download paper | 20 |
| 32 | 2012 | Valuation of the Child Health Utility 9D Index. (2012). Stevens, Katherine. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:729-747. Full description at Econpapers || Download paper | 19 |
| 33 | 2018 | Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Edney, Laura Catherine ; Karnon, Jonathan ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2. Full description at Econpapers || Download paper | 19 |
| 34 | 2015 | Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Arnberg, Karl ; Nilsson, Fredrik. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236. Full description at Econpapers || Download paper | 18 |
| 35 | 2011 | Do Productivity Costs Matter?. (2011). Brouwer, Werner ; Krol, Marieke ; Koopmanschap, Marc ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619. Full description at Econpapers || Download paper | 18 |
| 36 | 2016 | Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Verguet, Stephane ; Kim, Jane J ; Jamison, Dean T. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z. Full description at Econpapers || Download paper | 18 |
| 37 | 2018 | Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Janssen, Mathieu F ; Bonsel, Gouke J. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. Full description at Econpapers || Download paper | 17 |
| 38 | 2015 | Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Froud, Robert ; Rivero-Arias, Oliver ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:985-991. Full description at Econpapers || Download paper | 16 |
| 39 | 2018 | Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4. Full description at Econpapers || Download paper | 16 |
| 40 | 2017 | A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. (2017). Brazier, John ; Ara, Roberta ; Chevrou-Severac, Helene ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0545-x. Full description at Econpapers || Download paper | 16 |
| 41 | 2015 | Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Clement, Fiona ; Godman, Brian ; Elshaug, Adam ; Crausaz, Steffan ; Garner, Sarah ; Pearson, Sallie-Anne ; Lopert, Ruth ; Choudhury, Moni. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924. Full description at Econpapers || Download paper | 16 |
| 42 | 2012 | Losing Sight of the Wood for the Trees. (2012). Peasgood, Tessa ; Dolan, Paul ; Lee, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:1035-1049. Full description at Econpapers || Download paper | 15 |
| 43 | Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Muszbek, Noemi ; Ishak, K. ; Benedict, Agnes. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675. Full description at Econpapers || Download paper | 15 | |
| 44 | 2017 | Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. (2017). Krahn, Murray ; Ijzerman, Maarten J ; Koffijberg, Hendrik ; Fenwick, Elisabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0509-1. Full description at Econpapers || Download paper | 15 |
| 45 | 2010 | Using Conjoint Analysis and Choice Experiments to Estimate QALY Values. (2010). Flynn, Terry. In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:9:p:711-722. Full description at Econpapers || Download paper | 15 |
| 46 | 2007 | Rates and Probabilities in Economic Modelling. (2007). Fleurence, Rachael ; Hollenbeak, Christopher . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:1:p:3-6. Full description at Econpapers || Download paper | 15 |
| 47 | 2019 | Spillover Effects on Caregiversâ and Family Membersâ Utility: A Systematic Review of the Literature. (2019). James, Lyndon P ; Prosser, Lisa A ; Wittenberg, Eve. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7. Full description at Econpapers || Download paper | 15 |
| 48 | 2016 | From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. (2016). Brouwer, Werner ; Knies, Saskia ; Versteegh, Matthijs. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0431-y. Full description at Econpapers || Download paper | 15 |
| 49 | 2014 | Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Wisloff, Torbjorn ; Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild ; Movik, Espen ; Hamidi, Vida . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375. Full description at Econpapers || Download paper | 15 |
| 50 | 2013 | Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10. Full description at Econpapers || Download paper | 15 |
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 29 |
| 2 | 2019 | Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Soekhai, Vikas ; Bekker-Grob, Esther W ; Ellis, Alan R. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers || Download paper | 14 |
| 3 | 2014 | Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers || Download paper | 14 |
| 4 | 2016 | Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers || Download paper | 10 |
| 5 | 2017 | Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers || Download paper | 9 |
| 6 | 2024 | A Reporting Checklist for Discrete Choice Experiments in Health: The DIRECT Checklist. (2024). Meng, Yan ; Ride, Jemimah ; Goranitis, Ilias ; Lancsar, Emily ; Labond, Christine. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:10:d:10.1007_s40273-024-01431-6. Full description at Econpapers || Download paper | 8 |
| 7 | 2021 | The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). (2021). Kessler, Ronald C ; Berman, Richard ; Greenberg, Paul E ; Simes, Mark ; Fournier, Andree-Anne ; Sisitsky, Tammy ; Koenigsberg, Sarah H. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01019-4. Full description at Econpapers || Download paper | 8 |
| 8 | 2025 | The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review. (2025). Til, Janine Astrid ; Bekker-Grob, Esther Wilhelmina ; Alberta, Daisy Maria ; Maria, Catharina Gerarda ; Henricus, Sven Petrus ; Marceta, Stella Maria ; Bui, Michael ; Veldwijk, Jorien. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:8:d:10.1007_s40273-025-01495-y. Full description at Econpapers || Download paper | 8 |
| 9 | 2019 | Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Le, Phuc ; Mullen, Patricia Dolan ; Zhang, LU ; Chiyaka, Edward T ; Deshpande, Abhishek ; Nghiem, Van T. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. Full description at Econpapers || Download paper | 7 |
| 10 | 2016 | AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users. (2016). Feenstra, T L ; Vemer, P ; Al, M J ; Ramos, Corro I. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:4:d:10.1007_s40273-015-0327-2. Full description at Econpapers || Download paper | 7 |
| 11 | 2022 | Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L. (2022). Pickard, Simon A ; Gu, Ning Yan ; Nazari, Jonathan L. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01222-x. Full description at Econpapers || Download paper | 7 |
| 12 | 2020 | Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?. (2020). Devlin, Nancy ; Rivero-Arias, Oliver ; Ratcliffe, Julie ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00873-7. Full description at Econpapers || Download paper | 7 |
| 13 | 2023 | The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice. (2023). Brouwer, Werner ; Baal, Pieter ; Versteegh, Matthijs ; Wouterse, Bram. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:6:d:10.1007_s40273-023-01265-8. Full description at Econpapers || Download paper | 6 |
| 14 | 2019 | TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility. (2019). Buyukkaramikli, Nasuh C ; Al, Maiwenn ; Severens, Johan L. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00844-y. Full description at Econpapers || Download paper | 6 |
| 15 | 2018 | Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. Full description at Econpapers || Download paper | 6 |
| 16 | 2020 | International Valuation Protocol for the EQ-5D-Y-3L. (2020). Shah, Koonal ; Devlin, Nancy ; Rivero-Arias, Oliver ; Oppe, Mark ; Ramos-Goi, Juan M ; Stolk, Elly ; Kreimeier, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00909-3. Full description at Econpapers || Download paper | 6 |
| 17 | 2016 | EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Oppe, Mark ; Rand-Hendriksen, Kim ; Ramosgoi, Juan M. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers || Download paper | 5 |
| 18 | 2013 | How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers || Download paper | 5 |
| 19 | 2017 | A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. (2017). Brazier, John ; Ara, Roberta ; Chevrou-Severac, Helene ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0545-x. Full description at Econpapers || Download paper | 4 |
| 20 | 2022 | Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures. (2022). Lancsar, Emily ; Devlin, Nancy ; Roberts, Nia ; Huynh, Elisabeth ; Howell, Martin ; Harrison, Conrad ; Freijser, Louise ; Bailey, Cate ; Howard, Kirsten ; Mulhern, Brendan ; Dalziel, Kim ; Hayes, Alison ; Khan, Kamran ; Ratcliffe, Julie ; Petrou, Stavros ; Kwon, Joseph ; Daher, Shahd ; Craig, Jonathan ; Smith, Sarah ; Wong, Germaine ; Chen, Gang. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:4:d:10.1007_s40273-021-01128-0. Full description at Econpapers || Download paper | 4 |
| 21 | 2023 | The Use of a Discrete Choice Experiment Including Both Duration and Dead for the Development of an EQ-5D-5L Value Set for Australia. (2023). Lorgelly, Paula ; Lancsar, Emily ; Ratcliffe, Julie ; Street, Deborah ; Mulhern, Brendan ; Viney, Rosalie ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:4:d:10.1007_s40273-023-01243-0. Full description at Econpapers || Download paper | 4 |
| 22 | 2017 | International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Zouraq, Ismail Azzabi ; Chevrou-Severac, Helene ; Rowen, Donna ; Hout, Ben. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. Full description at Econpapers || Download paper | 4 |
| 23 | 2024 | Systematic Review of the Relative Social Value of Child and Adult Health. (2024). Wong, Germaine ; Norman, Richard ; Devlin, Nancy J ; Donaldson, Cam ; Howard, Kirsten ; Lancsar, Emily ; Coast, Joanna ; Raghunandan, Rakhee ; Chen, Gang ; Craig, Jonathan C ; Sellars, Marcus ; Howell, Martin ; Salisbury, Amber ; Peasgood, Tessa ; Viney, Rosalie ; Ratcliffe, Julie ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:2:d:10.1007_s40273-023-01327-x. Full description at Econpapers || Download paper | 4 |
| 24 | 2018 | Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?. (2018). Zozaya, Neboa ; Mestre-Ferrandiz, Jorge ; Alcala, Bleric ; Hidalgo-Vega, Alvaro. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0716-4. Full description at Econpapers || Download paper | 4 |
| 25 | 2021 | Productivity-Adjusted Life-Years: A New Metric for Quantifying Disease Burden. (2021). Ademi, Zanfina ; Ackerman, Ilana N ; Zomer, Ella ; Liew, Danny. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:3:d:10.1007_s40273-020-00999-z. Full description at Econpapers || Download paper | 4 |
| 26 | 2021 | Valuing SF-6Dv2 in Australia Using an International Protocol. (2021). Norman, Richard ; Brazier, John ; Mulhern, Brendan. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:10:d:10.1007_s40273-021-01043-4. Full description at Econpapers || Download paper | 4 |
| 27 | 2015 | Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Froud, Robert ; Rivero-Arias, Oliver ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:985-991. Full description at Econpapers || Download paper | 4 |
| 28 | 2012 | Valuation of the Child Health Utility 9D Index. (2012). Stevens, Katherine. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:729-747. Full description at Econpapers || Download paper | 4 |
| 29 | 2013 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Moher, David ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers || Download paper | 4 |
| 30 | 2020 | A French Value Set for the EQ-5D-5L. (2020). Andrade, Luiz ; Oppe, Mark ; Ludwig, Kristina ; Ramos, Juan Manuel ; Pouvourville, Gerard. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00876-4. Full description at Econpapers || Download paper | 4 |
| 31 | 2021 | How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment. (2021). Schlander, Michael ; Baumann, Michael ; Hernandez-Villafuerte, Karla ; Mestre-Ferrandiz, Jorge ; Cheng, Chih-Yuan. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:11:d:10.1007_s40273-021-01065-y. Full description at Econpapers || Download paper | 3 |
| 32 | 2018 | German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. Full description at Econpapers || Download paper | 3 |
| 33 | 2014 | The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86. Full description at Econpapers || Download paper | 3 |
| 34 | 2019 | Spillover Effects on Caregiversâ and Family Membersâ Utility: A Systematic Review of the Literature. (2019). James, Lyndon P ; Prosser, Lisa A ; Wittenberg, Eve. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7. Full description at Econpapers || Download paper | 3 |
| 35 | 2017 | The Use of Mapping to Estimate Health State Utility Values. (2017). Ara, Roberta ; Rowen, Donna ; Mukuria, Clara. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0548-7. Full description at Econpapers || Download paper | 3 |
| 36 | 2022 | Correction to: Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures. (2022). Lancsar, Emily ; Devlin, Nancy ; Howell, Martin ; Harrison, Conrad ; Freijser, Louise ; Bailey, Cate ; Howard, Kirsten ; Mulhern, Brendan ; Dalziel, Kim ; Khan, Kamran ; Hayes, Alison ; Ratcliffe, Julie ; Petrou, Stavros ; Kwon, Joseph ; Daher, Shahd ; Craig, Jonathan ; Smith, Sarah ; Wong, Germaine ; Chen, Gang ; Roberts, Nia ; Huynh, Elisabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:4:d:10.1007_s40273-022-01135-9. Full description at Econpapers || Download paper | 3 |
| 37 | 2014 | Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers || Download paper | 3 |
| 38 | 2023 | Modelling Spillover Effects on Informal Carers: The Carer QALY Trap. (2023). Guest, Sophie ; Pennington, Becky ; Scheuer, Nicolas ; Shah, Koonal K ; Schirrmacher, Hannah ; Mott, David J ; Skedgel, Chris ; Al-Janabi, Hareth. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:12:d:10.1007_s40273-023-01316-0. Full description at Econpapers || Download paper | 3 |
| 39 | 2014 | A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers || Download paper | 3 |
| 40 | 2024 | Bring Out Your Dead: A Review of the Cost Minimisation Approach in Health Technology Assessment Submissions to the Australian Pharmaceutical Benefits Advisory Committee. (2024). Norman, Alicia ; Tirrell, Zachary ; Hoyle, Martin ; Lybrand, Sean ; Parkinson, Bonny. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:11:d:10.1007_s40273-024-01420-9. Full description at Econpapers || Download paper | 3 |
| 41 | 2015 | A Practical Guide to Value of Information Analysis. (2015). Wilson, Edward. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:105-121. Full description at Econpapers || Download paper | 3 |
| 42 | 2022 | The EQ-5D-5L Valuation Study in Egypt. (2022). al Shabasy, Sahar ; Abbassi, Maggie ; Baines, Darrin ; Roudijk, Bram ; Finch, Aureliano ; Farid, Samar. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:4:d:10.1007_s40273-021-01100-y. Full description at Econpapers || Download paper | 3 |
| 43 | 2020 | External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions. (2020). Johansen, Pierre ; Lopes, Sandra ; McEwan, Phil ; Lamotte, Mark ; Olivieri, Anamaria-Vera ; Foos, Volker. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00941-3. Full description at Econpapers || Download paper | 3 |
| 44 | 2022 | Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. (2022). Norman, Richard ; Rivero-Arias, Oliver ; Devlin, Nancy J ; Shah, Koonal K ; Mott, David J ; Kreimeier, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01214-x. Full description at Econpapers || Download paper | 3 |
| 45 | 2022 | Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review. (2022). Ward, Thomas ; Mujica-Mota, Ruben E ; Medina-Lara, Antonieta ; Spencer, Anne E. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:1:d:10.1007_s40273-021-01094-7. Full description at Econpapers || Download paper | 3 |
| 46 | 2018 | A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5. Full description at Econpapers || Download paper | 3 |
| 47 | 2016 | From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. (2016). Brouwer, Werner ; Knies, Saskia ; Versteegh, Matthijs. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0431-y. Full description at Econpapers || Download paper | 3 |
| 48 | 2014 | How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers || Download paper | 3 |
| 49 | 2024 | Proxy Preferences and the Values of Childrenâs Health States. (2024). Hausman, Daniel M. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:10:d:10.1007_s40273-024-01415-6. Full description at Econpapers || Download paper | 3 |
| 50 | 2024 | Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis. (2024). Lloyd, Melanie ; Morton, Jedidiah I ; Watts, Gerald F ; Liew, Danny ; Marquina, Clara ; Ademi, Zanfina ; Zoungas, Sophia. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:1:d:10.1007_s40273-023-01306-2. Full description at Econpapers || Download paper | 2 |
| Year | Title | |
|---|---|---|
| 2026 | Cost-utility analysis of eptinezumab for migraine prevention in Taiwan. (2026). Huang, Tzu-Yao ; Chan, Cheng-Shen ; Hsieh, Ping-Hsuan ; Ruan, Yuan-Zhen ; Liu, YI ; Yang, Fu-Chi ; Lin, Tsung-Kun ; Tseng, Wei-Hsuan. In: Health Economics Review. RePEc:spr:hecrev:v:16:y:2026:i:1:d:10.1186_s13561-025-00711-x. Full description at Econpapers || Download paper | |
| 2026 | EQ-5D(-Y) Valuation from Adult and Child Perspectives: Where Does the Empirical Evidence Leave Us and How Should We Proceed?. (2026). Guo, Zhirui ; Lipman, Stefan A. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:3:d:10.1007_s40273-026-01589-1. Full description at Econpapers || Download paper | |
| 2026 | Valuing health states for infants and toddlers: challenges and methodological considerations in EQ-TIPS preference elicitation. (2026). Stolk, Elly ; Herdman, Michael ; Roudijk, Bram ; Devlin, Nancy ; Verstraete, Janine ; Kreimeier, Simone ; Norman, Richard. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:27:y:2026:i:2:d:10.1007_s10198-025-01789-0. Full description at Econpapers || Download paper | |
| 2026 | Nothing about us, without us? A reflection on and call for involving children in the process of valuing child health. (2026). Brouwer, Werner ; Lipman, Stefan ; Reckers-Droog, Vivian ; Hoogenboom, Ava. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:27:y:2026:i:2:d:10.1007_s10198-025-01823-1. Full description at Econpapers || Download paper | |
| 2026 | A Systematic Literature Review of Preference Studies in Migraine Treatments. (2026). Clarke, Harrison ; Mohan, Divya ; Ramachandran, Natasha ; Seo, Jaein. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:19:y:2026:i:1:d:10.1007_s40271-025-00768-0. Full description at Econpapers || Download paper | |
| 2026 | Public Preferences for Emerging Cancer Screening Modalities: A Systematic Review of Discrete Choice Experiments. (2026). Gao, QI ; Har, Chee Ern ; Wang, YI ; Chen, Wenjia. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:19:y:2026:i:2:d:10.1007_s40271-025-00775-1. Full description at Econpapers || Download paper | |
| 2026 | Reducing Primary Healthcare Bypass Behaviour: A Discrete Choice Experiment Study Exploring the Preferences for Primary Eye Care Services in Rural Xinjiang. (2026). Zhao, Junling ; Dong, Xiaodong ; Ma, Xiaochen ; Su, Can. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:19:y:2026:i:2:d:10.1007_s40271-025-00781-3. Full description at Econpapers || Download paper | |
| 2026 | Factors influencing Patient Preferences for BRCA Testing and Adjuvant Therapy in HER2-Negative Early Breast Cancer in the United States: BestâWorst Scaling and Discrete Choice Experiment. (2026). Li, Qixin ; Xu, Xiaoqing ; Mishkin, Kathryn ; Gordon, Alexandra ; Honomichl, Ryan ; Mulvihill, Emily ; Beusterien, Kathleen ; Lankin, Josh ; Krupsky, Kathryn ; Hirshfield, Kim M ; Mejia, Jaime A ; Earla, Jagadeswara Rao. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:19:y:2026:i:2:d:10.1007_s40271-025-00783-1. Full description at Econpapers || Download paper | |
| 2026 | Cost-effectiveness of Mavacamten for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy using a French healthcare perspective. (2026). Hurst, Michael ; Cott, Francois-Emery ; Leproust, Sandy ; Chambry, Lou ; Vernon, Julien ; Ho, Melissa ; Akarkoub, Sarah. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:27:y:2026:i:1:d:10.1007_s10198-025-01808-0. Full description at Econpapers || Download paper | |
| 2026 | A Post-Market Economic Evaluation of Bortezomib, Lenalidomide and Dexamethasone Versus Pre-funding Standard of Care for Newly Diagnosed Multiple Myeloma Using Registry Data. (2026). Petrie, Dennis ; Spencer, Andrew ; Fanning, Laura ; Irving, Adam ; Cook, Gordon ; McCaughan, Georgia ; Gay, Francesca ; Wood, Erica M ; Moore, Elizabeth ; McQuilten, Zoe K ; Wellard, Cameron ; Augustson, Bradley ; Mollee, Peter ; Harris, Anthony ; Waters, Neil. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:1:d:10.1007_s40273-025-01554-4. Full description at Econpapers || Download paper | |
| 2026 | Model-Based Economic Analyses of Haemophilia from a Societal Perspective: A Scoping Review. (2026). Bolous, Nancy S ; El-Sayed, Amr A. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:10:y:2026:i:1:d:10.1007_s41669-025-00618-7. Full description at Econpapers || Download paper | |
| 2026 | Cure Models: What is Meant by a Survival âPlateauâ, and Do Experts Agree on What Constitutes One?. (2026). Jackson, Dan ; Yu, Binbing ; Baker, Rose ; Hettle, Robert ; Hawkins, Neil ; Sweeting, Michael ; Abrams, Keith. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:1:d:10.1007_s40273-025-01546-4. Full description at Econpapers || Download paper | |
| 2026 | The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective. (2026). Fernandez-Garcia, Cristina ; Wu, Hangjian ; Rice, Stephen ; Meader, Nick ; Beyer, Fiona ; Gonzalez-Moral, Sonia Garcia ; Ogunyemi, Ayomikun ; Akinbolade, Sola ; Williams, Oleta ; Oconnor, Nicole. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:3:d:10.1007_s40273-025-01570-4. Full description at Econpapers || Download paper | |
| 2026 | Comment on âCost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspectiveâ by Marten J. Poley et al.. (2026). Lovell, Alan ; Abdelsabour, Ahmed ; Melendez-Torres, G J ; Lee, Dawn ; Allen, Alexander. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:1:d:10.1007_s40273-025-01551-7. Full description at Econpapers || Download paper | |
| 2026 | Exploring the Generalizability of Foreign Cost-Effectiveness Analysis to Spain Using Data From a Scoping Review of Multinational Studies. (2026). Garca-Prez, Lidia ; Absolo-Alessn, Ignacio ; Negrn-Hernndez, Miguel Ngel. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:1:d:10.1007_s40273-025-01541-9. Full description at Econpapers || Download paper | |
| 2026 | Comparison of the psychometric performance of experimental EuroQol Toddler and Infant Populations Instrument (EQ-TIPS) and Pediatric Quality of Life Inventory⢠(PedsQL) in young children. (2026). Verstraete, Janine ; He, Vicky ; Huang, LI ; Pan, Tianxin ; Dalziel, Kim ; Herdman, Mike ; Devlin, Nancy. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:27:y:2026:i:2:d:10.1007_s10198-025-01804-4. Full description at Econpapers || Download paper | |
| 2026 | The Influence of Perspective on the Valuation of the EQ-5D-Y-3L: A Comparison Using the OPUF Tool and a Discrete Choice Experiment. (2026). Kumar, Gayathri ; Mott, David ; Schneider, Paul ; Devlin, Nancy ; Shah, Koonal ; Hitch, Jake. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:1:d:10.1007_s40273-025-01545-5. Full description at Econpapers || Download paper | |
| 2026 | Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes. (2026). Howell, Martin ; Killedar, Anagha ; Norris, Sarah ; Howard, Kirsten. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:3:d:10.1007_s40273-025-01568-y. Full description at Econpapers || Download paper | |
| 2026 | A scoping review of preference-based instruments for measuring carer outcomes in economic evaluations. (2026). Ratcliffe, Julie ; Al-Janabi, Hareth ; Currow, David ; Hutchinson, Claire ; Karnon, Benjamin ; Rand, Stacey ; Hoefman, Renske ; McCaffrey, Nikki ; Frith, Madison ; Engel, Lidia. In: Social Science & Medicine. RePEc:eee:socmed:v:390:y:2026:i:c:s0277953625010937. Full description at Econpapers || Download paper | |
| 2026 | Caring for and Caring about in Economic Evaluation: Modelling the Family and Caregiving Effects. (2026). Cranmer, Holly ; Pennington, Becky ; Davis, Sarah. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:1:d:10.1007_s40273-025-01540-w. Full description at Econpapers || Download paper | |
| 2026 | Data-Related and Methodological Challenges in Assessing the Cost-Effectiveness of Traditional and Genomic Newborn Screening Programs. (2026). Grosse, Scott D ; Smith, Hadley Stevens ; Lamsal, Ramesh. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:24:y:2026:i:2:d:10.1007_s40258-025-01013-3. Full description at Econpapers || Download paper | |
| 2026 | Book Chapter: Pharmaceutical Pricing. (2026). Cai, Yong ; Wen, Siqi ; Yu, Siyi ; Liu, Qiang. In: SocArXiv. RePEc:osf:socarx:vsb8j_v1. Full description at Econpapers || Download paper | |
| 2026 | Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology Assessment. (2026). Hglinger, Gnter ; Krismer, Florian ; Strm, Daniel Oudin ; Bidani, Aroussi ; Poewe, Werner ; Grand, Tobias Sydendal ; Regnier, Stephane ; Zanigni, Stefano ; Ren, Shijie ; Thokala, Praveen. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:10:y:2026:i:1:d:10.1007_s41669-025-00609-8. Full description at Econpapers || Download paper | |
| 2026 | The âValues in Modellingâ Framework for Patient and Public Involvement in Health Economics Modelling: Development and Application in the LEAP Model Project. (2026). Carter, Rachel ; Harvard, Stephanie ; Johnson, Kate M ; Winsberg, Eric B ; Ewert, Mark ; Novacovik, Cristina ; Lee, Spencer ; Adibi, Amin ; Zeyan, Zainab ; Lanier, Tony ; Cheong, Sian Hoe. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:2:d:10.1007_s40273-025-01561-5. Full description at Econpapers || Download paper | |
| 2026 | Politicised Changes to the NICE Threshold Risk Making Cost-Effectiveness Analysis Performative, Not Informative. (2026). Espinosa Acuña, Oscar ; Vanness, David J ; Howdon, Daniel ; Paulden, Mike ; Longo, Francesco ; Karnon, Jonathan ; Edney, Laura C ; Vallejo-Torres, Laura. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:24:y:2026:i:2:d:10.1007_s40258-025-01026-y. Full description at Econpapers || Download paper | |
| 2026 | Economic Consequences of Increasing the NICE Cost-Effectiveness Threshold. (2026). Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:1:d:10.1007_s40273-025-01579-9. Full description at Econpapers || Download paper | |
| 2026 | Valuing health and wellbeing using discrete choice experiment: exploring feasibility, design effect and international preference similarity. (2026). Mukuria, Clara ; Chen, Yuen ; Rowen, Donna L ; Wang, Haode ; Norman, Richard ; Street, Deborah. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:27:y:2026:i:2:d:10.1007_s10198-025-01821-3. Full description at Econpapers || Download paper | |
| 2026 | External Validation of the MicroSimulation Core Obesity Model (MS-COM) to Predict Cardiovascular Outcomes, Mortality and Type 2 Diabetes Mellitus Incidence and Assess Cost Effectiveness. (2026). Thom, Howard ; Fawsitt, Christopher G ; Foos, Volker ; Keeney, Edna ; Kayongo, Edward ; Lbker, Christopher ; Larsen, Sara ; Jarde, Alexander ; Aceituno, David. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:2:d:10.1007_s40273-025-01555-3. Full description at Econpapers || Download paper | |
| 2026 | General population preferences for health-related protective behaviors during infectious disease emergencies: a systematic review of conjoint-analysis studies. (2026). Hiligsmann, Mickal ; Steijvers, Lisanne ; Kojan, Lilian ; Stellbrink, Leonard ; Chevalier, Joshua M ; Siebert, Uwe ; van Daalen, Florian ; Wijnen, Senne ; Jahn, Beate ; Crutzen, Rik ; Rambod, Baharak ; Dukers-Muijrers, Nicole ; Kretzschmar, Mirjam. In: Social Science & Medicine. RePEc:eee:socmed:v:388:y:2026:i:c:s0277953625010524. Full description at Econpapers || Download paper | |
| 2026 | Attribute Development and Level Selection for a Discrete Choice Experiment to Elicit Care Preferences of Older Adults and Informal Caregivers Aging in Place in The Netherlands. (2026). Swait, Joffre ; MacNeil, Janet L ; Vullings, Isabelle ; Uysal-Bozkir, Zgl ; Pilli, Luis ; Wammes, Joost. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:19:y:2026:i:1:d:10.1007_s40271-025-00774-2. Full description at Econpapers || Download paper | |
| 2026 | How Important is Healthcare-Contact Time to Systemic Treatment Decision-Making in Advanced Gastrointestinal Cancers: Developing Attributes to Include in a Discrete Choice Experiment. (2026). El-Katateny, Ella ; Stevens, Samuel X ; de Abreu, Richard ; Vardy, Janette L ; Shaw, Joanne ; Booth, Christopher ; Street, Deborah ; Addo, Isaac Yeboah. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:19:y:2026:i:2:d:10.1007_s40271-025-00778-y. Full description at Econpapers || Download paper | |
| 2026 | Reply to Comment on âCost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspectiveâ. (2026). Ramos, Isaac Corro ; Yang, Huiqin ; Armstrong, Nigel ; Patel, Mubarak ; Poley, Marten J ; Al, Maiwenn J ; Stirk, Lisa. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:1:d:10.1007_s40273-025-01553-5. Full description at Econpapers || Download paper | |
| 2026 | Who Prefers Death to Life in Composite Time Trade-off Interviews, and Why? A Mixed-Methods Study among Asians in Singapore. (2026). Thakumar, Annushiah Vasan ; Cheng, Ling Jie ; Luo, Nan ; Liao, Meixia ; Tan, Rachel Lee-Yin. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:19:y:2026:i:2:d:10.1007_s40271-025-00777-z. Full description at Econpapers || Download paper |
| Year | Citing document | |
|---|---|---|
| 2025 | The racial politics of visibility and equity in genome-editing therapies for sickle cell disease. (2025). Molina, Santiago J ; Creary, Melissa. In: Social Science & Medicine. RePEc:eee:socmed:v:383:y:2025:i:c:s027795362500783x. Full description at Econpapers || Download paper | |
| 2025 | Visualizing risk: Risk graphicsâ impact on patient understanding and choices in discrete choice experiments. (2025). Marceta, Stella M ; Veldwijk, Jorien ; de Bekker-Grob, Esther W. In: Social Science & Medicine. RePEc:eee:socmed:v:384:y:2025:i:c:s0277953625008354. Full description at Econpapers || Download paper | |
| 2025 | Integrating Equity and Productivity in Health Evaluation. (2025). Ãsterdal, Lars Peter ; Moreno-Ternero, Juan ; Hansen, Kristian S. In: Working Papers. RePEc:hhs:cbsnow:2025_009. Full description at Econpapers || Download paper | |
| 2025 | Antimicrobial Resistance (AMR) Development Map: A Conceptual Map and a Tool to Support Economic Evaluation of AMR Interventions. (2025). Robotham, Julie ; Hope, William ; Hewitt, Catherine ; Soares, Marta O ; Aluzaite, Kristina ; Woods, Beth. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:23:y:2025:i:5:d:10.1007_s40258-025-00969-6. Full description at Econpapers || Download paper | |
| 2025 | The Impact of Alteplase Coverage on Health Equity for the Treatment of Ischemic Stroke in the USA: A Distributional Cost-Effectiveness Analysis. (2025). Majda, Thomas ; Kowal, Stacey ; Mearns, Elizabeth S. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:23:y:2025:i:6:d:10.1007_s40258-025-00985-6. Full description at Econpapers || Download paper | |
| 2025 | Measuring and Valuing Health Using EuroQol Instruments: New Developments 2025 and Beyond. (2025). Devlin, Nancy J ; Xie, Feng ; Stolk, Elly ; Slaap, Bernhard. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:23:y:2025:i:6:d:10.1007_s40258-025-00989-2. Full description at Econpapers || Download paper | |
| 2025 | Developing Tools for the Efficient Design of Health Preference Studies: Taxonomy of Attributes and Prototype of an Attribute Library. (2025). Liden, Barry ; Reed, Shelby D ; Hanna, Alissa ; Crossnohere, Norah L ; Gunasekaran, Kert ; Gonzalez, Juan Marcos ; Golder, Jonah ; Bekker-Grob, Esther W ; Janssen, Ellen M ; Marshall, Deborah ; Poulos, Christine ; Levitan, Bennett. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:18:y:2025:i:6:d:10.1007_s40271-025-00751-9. Full description at Econpapers || Download paper | |
| 2025 | The Cost-Effective Price of Lecanemab for Patients with Early Alzheimerâs Disease in Sweden. (2025). Winblad, Bengt ; Xia, Xin ; Wimo, Anders ; Skillbck, Tobias Borgh ; Kern, Silke ; Aye, Sandar ; Handels, Ron ; Frisell, Oskar ; Eriksdotter, Maria ; Jnsson, Linus ; Zetterberg, Henrik ; Aho, Emil ; Li, Yunfei. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:10:d:10.1007_s40273-025-01527-7. Full description at Econpapers || Download paper | |
| 2025 | Eliciting and Anchoring Health State Preferences Using Discrete Choice Experiments Among Adults, Adolescents, and Children. (2025). Xie, Feng ; Mulhern, Brendan ; Yang, Zhihao ; Pan, Tianxin ; Norman, Richard ; Devlin, Nancy ; Ramos-Goni, Juan Manuel. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:11:d:10.1007_s40273-025-01530-y. Full description at Econpapers || Download paper | |
| 2025 | Highlights from the Manifesto on the Health Economics of Cardiovascular Disease Prevention. (2025). Vivoda, Karl ; Ware, James S ; Ademi, Zanfina ; Hennessy, Susan ; Rodda, Sheridan E ; Fenton, Olive. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:11:d:10.1007_s40273-025-01537-5. Full description at Econpapers || Download paper | |
| 2025 | Scoping Review of Productivity-Adjusted Life Years (PALYs): Methods, Applications and Policy Implications. (2025). Liew, Danny ; Marquina, Clara ; Ademi, Zanfina ; Lavikainen, Piia ; Lloyd, Melanie ; Alfonso, Maria J ; Vivoda, Karl ; Martikainen, Janne ; Abushanab, Dina. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:12:d:10.1007_s40273-025-01544-6. Full description at Econpapers || Download paper | |
| 2025 | Reply to Comment on âExamining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal Haemoglobinuriaâ. (2025). Gallacher, Daniel. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:7:d:10.1007_s40273-025-01499-8. Full description at Econpapers || Download paper | |
| 2025 | Comment on âExamining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal Haemoglobinuriaâ. (2025). Woods, Matthew ; Gladwell, Daniel ; Farrar, Benjamin. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:7:d:10.1007_s40273-025-01500-4. Full description at Econpapers || Download paper |
| Year | Citing document | |
|---|---|---|
| 2024 | âManaging valuesâ in health economics modelling: Philosophical and practical considerations. (2024). Winsberg, Eric B ; Harvard, Stephanie. In: Social Science & Medicine. RePEc:eee:socmed:v:358:y:2024:i:c:s027795362400710x. Full description at Econpapers || Download paper | |
| 2024 | An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?. (2024). Kim, Inkyu ; Chen, Clara ; Okorogheye, Gabriel ; Ho, Sophia ; Hatswell, Anthony J ; Taylor, Kurt ; Latimer, Nicholas R ; Bertwistle, David ; Borrill, John. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:12:d:10.1007_s40273-024-01429-0. Full description at Econpapers || Download paper | |
| 2024 | Meeting the Challenges of Preference-Weighted Health-Related Quality-of-Life Measurement in Children. (2024). Ungar, Wendy J ; Herdman, Michael. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:1:d:10.1007_s40273-024-01383-x. Full description at Econpapers || Download paper | |
| 2024 | Advancing Methods to Measure and Reward Healthcare Innovation. (2024). Xie, Richard ; Chapman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:2:d:10.1007_s40273-024-01408-5. Full description at Econpapers || Download paper |
| Year | Citing document | |
|---|---|---|
| 2023 | The Risk of Household Socioeconomic Deprivation Related to Older Long-Term Care Needs: A Qualitative Exploratory Study in Italy and Spain. (2023). Fernandez-Salido, Mirian ; Casanova, Georgia ; Moreno-Castro, Carolina. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:20:p:15031-:d:1262507. Full description at Econpapers || Download paper | |
| 2023 | Values in Modelling: Video Series Development and Evaluation Survey. (2023). Werker, Greg ; Murphy, David ; Adibi, Amin ; McLean, Alison ; Easterbrook, Adam ; Harvard, Stephanie. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:5:d:10.1007_s40258-023-00820-w. Full description at Econpapers || Download paper | |
| 2023 | Estimating the Potential Benefits of Confirmatory Trials for Drugs with Accelerated Approval: A Comprehensive Value of Information Framework. (2023). Jiao, Boshen. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:12:d:10.1007_s40273-023-01303-5. Full description at Econpapers || Download paper | |
| 2023 | Modelling Spillover Effects on Informal Carers: The Carer QALY Trap. (2023). Guest, Sophie ; Pennington, Becky ; Scheuer, Nicolas ; Shah, Koonal K ; Schirrmacher, Hannah ; Mott, David J ; Skedgel, Chris ; Al-Janabi, Hareth. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:12:d:10.1007_s40273-023-01316-0. Full description at Econpapers || Download paper | |
| 2023 | The Carer QALY Trap and Altruism in Economic Evaluations. (2023). Tilford, Mick J ; Tarlan, Aygul. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:12:d:10.1007_s40273-023-01324-0. Full description at Econpapers || Download paper | |
| 2023 | Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States. (2023). Pearman, Leny ; Caminis, John ; Reginster, Jean-Yves ; Mathew, Jake ; Singer, Andrea J ; Wang, Yamei ; Silverman, Stuart S ; Hiligsmann, Mickael. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:7:d:10.1007_s40273-023-01270-x. Full description at Econpapers || Download paper | |
| 2023 | Moving Forward with Taking a Societal Perspective: A Themed Issue on Productivity Costs, Consumption Costs and Informal Care Costs. (2023). Brouwer, Werner ; Baal, Pieter. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:9:d:10.1007_s40273-023-01307-1. Full description at Econpapers || Download paper |